Michael Narkewicz, MD


Specialties

Digestive Liver and Pancreas

Related Departments

Digestive Health Institute

Titles

Academic - Professor
Additional Academic - Pediatric Services Associate Clinical Director/Associate Dean for Pediatric Clinical Affairs
Department - Hewit-Andrews Chair in Pediatric Liver Disease
Department - Medical Director, Pediatric Liver Center

Recognitions/Awards

Top Doctor in Denver
Awarding Body: 5280 Magazine
Date: 2013
Description: Voted a 5280 best doctor by my peers in response to the question, "Which physician would you trust to treat you and your family?"

Biography & Interests

Clinical Interests

I am nationally recognized for my expertise in pediatric hepatology and liver transplantation and cystic fibrosis liver disease. I am also interested in chronic viral hepatitis, pediatric acute liver failure and chronic pancreatitis.

Research Interests

My research focuses on new therapies for children with hepatitis B and C. I lead a large study that is trying to develop tests that will predict which patients with cystic fibrosis are at risk for the development of advanced liver disease

Volunteer Activities

Round Up River Ranch volunteer physician. Medical Advisory Committee: American Liver Foundation

Education & Training

Medical Schools

University of Vermont  - Medicine (1983)

Internships

University of Colorado Health Sciences Center  - Pediatrics (1984)

Residency Program

University of Colorado Health Sciences Center  - Pediatrics (1986)

Fellowships

University of Colorado Health Sciences Center  - Pediatric Gastroenterology and Nutr (1989)

Undergraduate Schools

Dartmouth College  (1979)

Research & Grants

Prospective Study of Hepatic US to Predict Cirrhosis In Cystic Fibrosis
Sponsor: Cystic Fibrosis Foundation
Amount: 3,000,000
Begins: 2009

Pediatric Acute Liver Failure Study Group
Sponsor: NIDDK
Amount: 100,000
Begins: 2010

Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
Sponsor: NIH
Begins: 2012

A Two-Part, Open-Label, Single-Arm Phase 1/2 Study of Safety, Pharmacokinetics, and Efficacy of Telaprevir in Combination With Peginterferon alfa-2b and Ribavirin in Pediatric Subjects Aged 3 to 17 Infected With Genotype 1 Hepatitis C Virus
Sponsor: Vertex
Begins: 2012

Website: http://www.ncbi.nlm.nih.gov/pubmed?term="Narkewicz MR" [Author]

Primary Location

13123 E. 16th Avenue
B290
Aurora CO, 80045-7106

(720) 777-6669

(720) 777-7277

Locations

Children's Hospital Colorado on Anschutz Medical Campus